ESMO 2025: Darolutamide-Treated mHSPC Patients Show a More Durable and Stronger PSA Response vs Abiraterone
/ Alicia Morgans / Jan Andreasen
ESMO 2025: The Future of Oncology Will Be Built by Individuals
/ Jan Andreasen
EADV 2025: Psychological and Psychiatric Implications of Rosacea
/ Mohammad Jafferany